Alopecia refers to loss of hair from parts of the head or body. Sedentary lifestyle, and unhealthy diets is leading loss of hair among masses. Hormonal miss proportion and aging contribute to rising cases of hair loss. Overall rise in geriatric population and rising awareness and preference for surgical hair transplants and other such treatments is also a positive influence for the global market in the forecast period.
The market research study on “Alopecia Market (By Disease Type: Alopecia Areata, Androgenetic Alopecia; By End Users: Homecare Settings, Dermatology Clinics; By Distribution Channel: Prescriptions, OTC) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026” offers a detailed outlook, strategic recommendations, and insightful viewpoints on the global Alopecia market. The report also analyzes the key players operating in Alopecia market and identifies the key strategies deployed by them along with the market share of leading players.
The global Alopecia market is segmented as below:
Alopecia Market by Disease Type
Alopecia Market by End Users
Alopecia Market by Distribution Channel
Alopecia Market by Geography
The global alopecia market is expected to grow at a CAGR of around 5.0%. In 2018, the market was valued at 8.44 billion USD. Product developments are expected to drive the market growth in the near future. Recent product development such as introduction of rapidly acting JAK drugs approved by the U.S. Food and Drug Administration (FDA), developments of methods to stimulate hair growth using human pluripotent stem cells, development of PRP treatment, introduction of a new drug SM04554 which Specifically which stimulate hair growth in men are driving factors. Technological advancements and product like Hairmax Laser Comb, Follinex Massager Comb, Lifemax Infrared Hair Brush and Hair Growth Renewing lasers are some of the products built on advanced technology. The launch of new drugs and the treatment success rate and the clinical outcomes are some of the biggest drives.
The global alopecia market is segmented on the basis of types, end users, and distribution channel. On the basis of disease type, the global market is segmented into alopecia areata, and androgenetic alopecia. On the basis of end users, the market is segmented into homecare settings, dermatology clinics, and others. And on the basis of distribution channel, the market is categorized into prescriptions and OTC.
Geographical the Global Alopecia market is divided into five regions: North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
North America leads the market with and is expected to grow lucratively over the forecast period. Presence of technologically advanced healthcare infrastructure, High disposable income and availability of novel therapeutic options affecting to the treatment are some of the factors contributing to the high market share of North America.
Europe is expected to dominate in the near future owing to outburst of middle-aged population. Asia Pacific has also witnessed growth owning to a large population suffering from Alopecia and rising awareness affecting to the available therapeutic options are the key drivers. Latin America, Middle East and Africa are expected to have a sluggish growth. However, these region are expecting a healthy market growth owing to the huge opportunity for the market growth.
Some of the leading companies operating in the global alopecia market include Cipla,Dr. Reddy’s Laboratories Ltd, Merck & Co.,Viviscal, Regaine, Ranbaxy Laboratories Ltd, Kirkland Signature, Lexington International LLC, Vitabiotics, Alpecin - Dr. Kurt Wolff GmbH & Co, Johnson and Johnson, GlaxoSmithKline PLC